Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Long-Term Investments (2021 - 2023)

AVITA Medical (RCEL) has disclosed Long-Term Investments for 2 consecutive years, with $2.8 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Long-Term Investments changed N/A year-over-year to $2.8 million, compared with a TTM value of $2.8 million through Jun 2023, changed N/A, and an annual FY2022 reading of $6.9 million, changed N/A over the prior year.
  • Long-Term Investments was $2.8 million for Q2 2023 at AVITA Medical, down from $4.2 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $6.9 million in Q4 2022 and bottomed at $2.8 million in Q2 2023.